Study of a new medicine for enlarged prostate symptoms
Part of Kidney & urinary clinical trials.
This study tests a new medication (called DNN.65.21.005) for men with an enlarged prostate (also called benign prostatic hyperplasia, or BPH) who have bothersome urinary symptoms. The goal is to see if this medication safely relieves symptoms like frequent or difficult urination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 50 or older.
- You have symptoms like frequent or difficult urination caused by an enlarged prostate, not by infection or nerve problems.
- You do not have prostate cancer.
- You do not have severe urinary retention (inability to empty your bladder).
- You do not have Parkinson's disease or other nerve conditions that affect bladder function.
- You have not used certain prostate medications recently (like alpha-blockers within 7 days or finasteride within 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (DTT106) to help men who have both an enlarged prostate and erectile dysfunction. It aims to see if the drug improves erection problems safely when added to their current prostate treatment.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This trial tests whether combining two medicines works better than one alone for easing urinary symptoms caused by an enlarged prostate. If you have bothersome symptoms and a larger prostate, this study may help you find a more effective treatment.
This study compares a new once-daily pill to an existing medication for men with an enlarged prostate. It aims to see if the new pill is better at improving urinary symptoms and urine flow.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
Hear when a new Prostatic Hyperplasia, Benign trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.